Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
PXMP2
REST API REST API
Homo sapiens
PXMP2 is differentially expressed in 140 experiments: 68 organism parts: accumbens, adipose tissue, ... (66 more);, 52 disease states: normal, adrenocortical carcinoma, ... (50 more);, 53 cell types 236 cell lines 24 compound treatments and 40 other conditions.
Synonyms PMP22
Orthologs PXMP2_BOVIN (Bos taurus)   Pxmp2 (Mus musculus)   PXMP2 (Danio rerio)   ENSCING00000015049 (Ciona intestinalis)   Pxmp2 (Rattus norvegicus)   SYM1 (Saccharomyces cerevisiae)   CG7970 (Drosophila melanogaster)   pxmp2 (Xenopus laevis)   PXMP2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, membrane, peroxisomal membrane, peroxisome, integral to membrane, mitochondrion
InterPro Term Mpv17_PMP22
UniProt Accession Q9NR77, B4DX64, F5GXM0, F5GZF7, F5H768, F5H4N4
Search EB-eye ENSG00000176894
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-6573, E-GEOD-18105, E-MTAB-69, E-GEOD-7307, ... (8 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-22152, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, ... (21 experiments)

Factor Value U/D Experiments
A549
2
E-GEOD-6013, E-GEOD-3202
MCF-7
2
E-GEOD-20081, E-GEOD-19639
HT3
1
E-MTAB-37
NA18504
1
E-GEOD-19480
SW1573
1
E-MTAB-37
BFTC905
1
E-MTAB-37
230 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-20677, E-GEOD-4219, E-GEOD-11755, ... (26 experiments)

Factor Value U/D Experiments
monocyte
2
E-GEOD-22373, E-GEOD-11755
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18265
epithelial cell
1
E-GEOD-4483
1
E-TABM-130
CD34+ hematopoietic progenitor cell
1
E-GEOD-19240
embryonic stem cell
1
E-GEOD-26672
47 more value(s).


Disease state

studied in E-GEOD-19743, E-GEOD-6872, E-GEOD-3744, E-GEOD-15960, E-TABM-311, ... (22 experiments)

Factor Value U/D Experiments
chronic myelogenous leukemia
2
E-MTAB-37, E-GEOD-5550
juvenile idiopathic arthritis subtype systemic
1
E-GEOD-13501
blast phase chronic myelogenous leukemia
1
E-MTAB-37
no inhalation injury
1
E-GEOD-19743
acute lymphoblastic leukemia
1
E-MTAB-37
squamous cell carcinoma
1
E-MTAB-37
46 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-15205, E-TABM-782, E-GEOD-15811, E-MEXP-2590, ... (14 experiments)

Factor Value U/D Experiments
unknown
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
phenol
1
E-GEOD-6907
Cxcl12
1
E-GEOD-7307
TGF
1
E-GEOD-15205
estradiol
1
E-GEOD-20081
18 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
38
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-MEXP-1828, E-GEOD-19743, E-MTAB-37, E-GEOD-21374, E-GEOD-16363 ... (5 experiments)

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-21138, E-GEOD-19665

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-20847

Genotype
studied in E-TABM-763, E-GEOD-17476, E-TABM-868, E-TABM-601, E-GEOD-17347, ... (6 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-7011, E-MEXP-2657, E-GEOD-12773, E-GEOD-20504, E-GEOD-22278, ... (6 experiments)

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-MEXP-1290, E-MEXP-2069, ... (14 experiments)

Infection
studied in E-MEXP-561

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-MEXP-1403

Population
studied in E-MTAB-197

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-17400, E-GEOD-18995

Sex
studied in E-GEOD-7307, E-GEOD-16363

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-GEOD-2748

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-12198 ... (5 experiments)

Tumor grading
studied in E-GEOD-4290

Processing time: 0.382 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM